中医药治疗前列腺癌研究进展

doi:10.3969/j.issn.1000-8535.2021.05.030

广州医药 ›› 2021, Vol. 52 ›› Issue (5): 135-138.DOI: 10.3969/j.issn.1000-8535.2021.05.030

• 综述 • 上一篇

中医药治疗前列腺癌研究进展

张林洋, 朱玲玲, 朱国华

南京中医药大学第一临床医学院(南京 210046)

收稿日期:2021-03-08 出版日期:2021-09-20 发布日期:2021-11-24
通讯作者: 朱国华,E-mail:gloria0601@njucm.edu.cn
基金资助:
江苏省青年自然科学基金(BK20161052);江苏省大学生创新训练计划项目(201910315062Y)

Research progress of traditional Chinese medicine in the treatment of prostate cancer

ZHANG Linyang, ZHU Lingling, ZHU Guohua

First Clinical Medical College,Nanjing University of Chinese Medicine,Nanjing 210023,China

Received:2021-03-08 Online:2021-09-20 Published:2021-11-24

摘要/Abstract

摘要： 前列腺癌作为最常见的男性泌尿系统恶性肿瘤之一,目前常规治疗手段主要为手术、放化疗、内分泌治疗等,但后期并发症、治疗副作用等问题突出,且多转化为去势抵抗性前列腺癌,预后极差。既往研究已然证实,中医药在前列腺癌的治疗中可有效减少复发、减轻症状,提高患者生活质量。本文旨在总结近几年中医药对前列腺癌的研究,为往后的研究与临床治疗提供一些新的思路。

关键词: 中医药, 前列腺癌, 研究进展

Abstract: Prostate cancer(PCa) is one of the most common male urinary system malignancies.At present,conventional treatment methods are mainly surgery, radiotherapy and chemotherapy, endocrine therapy,etc.However, late complications, treatment side effects and other problems are prominent, and prostate cancer tends to develop as castration-resistant prostate cancer (CRPC), and the prognosis is very poor. Previous studies have confirmed that Chinese medicine can effectively reduce recurrence incidence, relieve symptoms and improve the quality of life of patients in the treatment of prostate cancer. This article summarizes the research of traditional Chinese medicine on prostate cancer in recent years, and provides some new ideas for future research and clinical treatment.

Key words: traditional Chinese medicine, prostate cancer (PCa), research progress

张林洋, 朱玲玲, 朱国华. 中医药治疗前列腺癌研究进展[J]. 广州医药, 2021, 52(5): 135-138.

ZHANG Linyang, ZHU Lingling, ZHU Guohua. Research progress of traditional Chinese medicine in the treatment of prostate cancer[J]. Guangzhou Medical Journal, 2021, 52(5): 135-138.

参考文献

[1] National Health Commission of the People's Republic of China. Chinese guidelines for diagnosis and treatment of prostate cancer 2018 (English version)[J].Chinese Journal of Cancer Research,2019,31(1):67-83.
[2] FENG R M,ZONG Y N, CAO S M,et al. Current cancer situationin China: good or bad news from the 2018 Global Cancer Statistics?[J]. Cancer Commun(Lond), 2019 ,39(1):22.
[3] 高瑞松,周青,张晓波,等.湖南部分地区2877例前列腺癌患者临床流行病学特征及流行学趋势分析[J].中华男科学杂志,2020,26(4):309-315.
[4] 刘德果,陈其华,李姿蓉,等.陈其华运用中医药辨治前列腺癌经验总结[J].中医药临床杂志,2020,32(12):2256-2259.
[5] 龚华,徐成林,郁超,等.前列负阴方治疗激素依赖性前列腺癌的临床对照研究[J].中国男科学杂志,2019,33(3):37-41.
[6] 任玮.前列负阴方联合西药治疗晚期前列腺癌的临床效果研究[J].中国现代药物应用,2020,14(9):192-194.
[7] 赖伟业,钟喨,黄智峰,等.前列负阴方联合抗雄药物治疗晚期前列腺癌的疗效[J].内蒙古中医药,2019,38(1):7-8.
[8] 徐文静,陈其华,宾东华.益肾通癃汤对前列腺癌去势治疗的减毒增效作用临床观察[J].湖南中医药大学学报,2020,40(5):617-620.
[9] 彭为. 金匮肾气汤联合内分泌治疗Ⅲ、Ⅳ期前列腺癌(肾阳虚证)临床研究[D].长沙:湖南中医药大学,2019.
[10] 刘书君. 生脉散加减联合内分泌治疗晚期气阴两虚型前列腺癌的临床疗效观察[D].哈尔滨:黑龙江中医药大学,2019.
[11] GHAFOURI-FARD S,SHOOREI H,TAHERI M.Role of microRNAs in the development, prognosis and therapeutic response of patients with prostate cancer[J]. Gene,2020(759):144995.
[12] 袁晟,陈栋,丘晨,等.姜黄素介导微小RNA-199a-3p基因对前列腺癌细胞的影响[J].中国临床药理学杂志,2021,37(2):124-127,132.
[13] 徐文静,陈其华,宾东华.益肾通癃汤对前列腺癌去势治疗的减毒增效作用临床观察[J].湖南中医药大学学报,2020,40(5):617-620.
[14] 黎毓光. miR-145-5p影响前列腺癌细胞增殖、迁移及其分子机制研究[D]. 广州:南方医科大学,2018:3-4.
[15] 王建良,李俊华,李兰兰,等. 天然产物白藜芦醇作用于前列腺癌的研究概述[J].甘肃科技,2018,34(23):122-125.
[16] KHUSBU F Y,ZHOU X,ROY M,et al. Resveratrol induces depletion of TRAF6 and suppresses prostate cancer cell proliferation and migration.[J]. The international journal of biochemistry & cell biology,2020,118:105644.
[17] 郑小蓉,姜建伟. 姜黄素阻断ERK1/2信号通路抑制前列腺癌PC-3细胞增殖的研究[J].全科医学临床与教育,2018,16(4):380-384.
[18] 郭巍,强亚勇,贺晓龙,等. 姜黄素联合顺铂对人前列腺癌PC-3细胞株的影响[J].中国临床保健杂志,2017,20(2):181-184.
[19] GUO W,WU X,LI Y,et al. Evaluation of biophysical as well as biochemical potential of curcumin and resveratrol during prostate cancer.[J].Journal of drug targeting,2020,28(1):41-45.
[20] 林棋,张鑫圣,刘世雄,等.白杨素调控Wnt/β-catenin通路对前列腺癌PC-3细胞株侵袭和迁移的影响[J].新中医,2020,52(18):9-13.
[21] 冯甜,刘盟,程路峰,等.基于凋亡和自噬途径的石榴皮多酚对人前列腺癌PC3细胞的抑制作用机制研究[J].中国药房,2020,31(16):1978-1983.
[22] 庞月文,巩会杰,王玲,等. 老鹳草素对去势抵抗性前列腺癌细胞增殖与迁移能力的影响[J].昆明医科大学学报,2019,40(8):22-27.
[23] ZHANG D,LIU S,LIU Z,et al. Polyphyllin I induces cell cycle arrest in prostate cancer cells via the upregulation of IL6 and P21 expression.[J]. Medicine,2019,98(44):e17743.
[24] LIU X,SUN Z,DENG J,et al. Polyphyllin I inhibits invasion and epithelial-mesenchymal transition via CIP2A/PP2A/ERK signaling in prostate cancer.[J]. International Journal of Oncology,2018,53(3):1279-1288.
[25] 张阳,姜华茂.川陈皮素对人前列腺癌DU145细胞生长的抑制作用及其机制[J].吉林大学学报(医学版),2020,46(6):1260-1266,1352.

中医药治疗前列腺癌研究进展

Research progress of traditional Chinese medicine in the treatment of prostate cancer

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 0

编辑推荐

Metrics

本文评价